Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Avibactam is a non-β-lactam β-lactamase inhibitor that has been approved in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and nosocomial pneumonia, including ventilator-associated pneumonia. In Europe, ceftazidime-avib...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Das, Shampa, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J., Newell, Paul, Melnick, David, Critchley, Ian A., Stone, Gregory G., Nichols, Wright W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2019
Soggetti:
Minireview
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437548/
https://ncbi.nlm.nih.gov/pubmed/30670413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02187-18
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi